Pancreatic ductal adenocarcinoma (PDAC) remains highly refractory to treatment. While th
Pancreatic ductal adenocarcinoma (PDAC) is a deadly disease, whose main molecular trait is the MAPK ...
Oncogenic Kras is increasingly appreciated as an instigator of an inflammatory program that facilita...
Activating mutations in the proto-oncogene KRAS are a hallmark of pancreatic ductal adenocarcinoma (...
Pancreatic ductal adenocarcinoma (PDAC) remains highly refractory to treatment. While the KRAS oncog...
Pancreatic ductal adenocarcinoma (PDA), the fourth leading cause of cancer death in the U.S., is a d...
Pancreatic cancer is a highly aggressive tumour that is very resistant to treatments and it is rarel...
Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer. PDAC is one of...
Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer. PDAC is one of...
Thesis: Ph. D., Massachusetts Institute of Technology, Department of Biology, 2016.Cataloged from PD...
Genetic alterations, especially the K-Ras mutation, carry the heaviest burden in the progression of ...
Pancreatic cancer is a highly aggressive tumour that is very resistant to treatments and it is rarel...
Genetic alterations, especially the K-Ras mutation, carry the heaviest burden in the progression of ...
Pancreatic cancer is the 4th leading cause of cancer related death in the United States with a media...
Pancreatic cancer is a lethal disease that is almost invariably associated with a KRAS gene mutation...
Pancreatic ductal adenocarcinoma (PDA) is a devastating malignancy with limited and modest clinical ...
Pancreatic ductal adenocarcinoma (PDAC) is a deadly disease, whose main molecular trait is the MAPK ...
Oncogenic Kras is increasingly appreciated as an instigator of an inflammatory program that facilita...
Activating mutations in the proto-oncogene KRAS are a hallmark of pancreatic ductal adenocarcinoma (...
Pancreatic ductal adenocarcinoma (PDAC) remains highly refractory to treatment. While the KRAS oncog...
Pancreatic ductal adenocarcinoma (PDA), the fourth leading cause of cancer death in the U.S., is a d...
Pancreatic cancer is a highly aggressive tumour that is very resistant to treatments and it is rarel...
Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer. PDAC is one of...
Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer. PDAC is one of...
Thesis: Ph. D., Massachusetts Institute of Technology, Department of Biology, 2016.Cataloged from PD...
Genetic alterations, especially the K-Ras mutation, carry the heaviest burden in the progression of ...
Pancreatic cancer is a highly aggressive tumour that is very resistant to treatments and it is rarel...
Genetic alterations, especially the K-Ras mutation, carry the heaviest burden in the progression of ...
Pancreatic cancer is the 4th leading cause of cancer related death in the United States with a media...
Pancreatic cancer is a lethal disease that is almost invariably associated with a KRAS gene mutation...
Pancreatic ductal adenocarcinoma (PDA) is a devastating malignancy with limited and modest clinical ...
Pancreatic ductal adenocarcinoma (PDAC) is a deadly disease, whose main molecular trait is the MAPK ...
Oncogenic Kras is increasingly appreciated as an instigator of an inflammatory program that facilita...
Activating mutations in the proto-oncogene KRAS are a hallmark of pancreatic ductal adenocarcinoma (...
DOI
Add to ORKG